Nephrotoxicity Related to Contrast Media

REFERENCES

• Almen T. Visipaque — a step forward. A historical review. Acta Radiol 1995; 36 (Suppl 399): 2–18.
   Google Scholar
• Kramer BK, Kammerl M, Schweda F, Schreiber M. A primer in radiocontrast-induced nephropathy. Nephrol Dial Transplant 1999; 14: 2830–4.
   PubMed Web of Science ®Google Scholar
• Frennby B Use of iohexol clearance to determine the glomerular filtration rate. Thesis, Malmo, 1996.
   Google Scholar
• Katzberg RW. Urography into the the 21st century: new contrast media, renal handling, imaging characteristics, and nephrotoxicity. Radiology 1997; 204: 297–312.
   PubMed Web of Science ®Google Scholar
• Heyman SN, Reichman J, Brezis M. Pathophysiology of radiocontrast nephropathy. A role for medullary hy-poxia. Invest Radiol 1999; 34: 685–91.
   Google Scholar
• Liss P. Nygren A, Olsson U, Ulfendahl FIR, Erikson U. Effect of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidney. Kidney Int 1996; 49: 1268–75.
   Google Scholar
• Heyman SN, Brezis M, Epstein FH, Spokes K, Silva P. Rosen S. Early renal medullary hypoxic injury from radiocontrast and indomethacin. Kidney Int 1991; 40: 632–42.
   Google Scholar
• Berg KJ, Jakobsen JA. Nephrotoxicity related to x-ray contrast media. Adv X-ray Contrast 1993; 1: 10–8.
   Google Scholar
• Dobrota M, Powell CJ, Holtz E, Wallin A, Vik H. Biochemical and morphological effects of contrast media on the kidney. Acta Radiol 1995; 36 (Suppl 399): 196–203.
   Google Scholar
• Porter GA. Radiocontrast-induced nephropathy. Nephrol Dial Transplant 1994; 9 (Suppl 4): 146–56.
   PubMedGoogle Scholar
• Humes HD, Hunt DA, White MD. Direct toxic effect of the radiocontrast agent diatrizoate on renal proximal tubule cells. Am J Physiol 1987; 252: F246–55.
   Google Scholar
• Nordby A, Halgunset J, Haugen OA. Effect of radio-graphic contrast media on monolayer cell cultures. Invest Radiol 1986; 21: 234–9.
   Google Scholar
• Erley CM, Duda SH, Rehfuss D, Scholtes B, Bock J, Milner C, et al. Prevention of radiocontrast-media-induced nephropathy in patients with pre-existing renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Trans-plant 1999; 14: 1146–9.
   PubMed Web of Science ®Google Scholar
• Katholi RF, Taylor GJ, McCann WP, Woods WT, Womack KA, McCoy CD, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiol-ogy 1995; 195: 17–22.
   PubMed Web of Science ®Google Scholar
• Murphy SW, Barrett BJ, Parfrey PS. Contrast nephro-pathy. J Am Soc Nephrol 2000; 11: 177–82.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Burnett JC Jr. A role for calcium in radiocontrast-induced reduction in renal hemodynamics. Kidney Int 1985; 27: 465–8.
   PubMed Web of Science ®Google Scholar
• Neumayer 1111, Junge W, Ktifner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxi-city by the calcium channel blocker nitrendipine: a prospective randomised trial. Nephrol Dial Transpl 1989; 4: 1030–6.
   Google Scholar
• Cantley LG, Spokes K, Clark B, McMahon EG, Carter J, Epstein FH. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993; 44: 1217–23.
   PubMed Web of Science ®Google Scholar
• Brooks DP, DePalma PD. Blockade of radiocontrast-induced nephrotoxicity by the endothelin receptor antagonist, SB 209670. Nephron 1996; 72: 629–36.
   PubMed Web of Science ®Google Scholar
• Bakris GL, Lass N, Osama Gaber A, Jones JD, Burnett C Jr. Radiocontrast medium-induced decline in renal function: a role for oxygen free radicals. Am J Physiol 1990; 258: F115–20.
   Google Scholar
• Morcos SK, Thomsen HS, Webb JAW. Contrast-media-induced nephrotoxicity: a consensus report. Eur Radiol 1999; 9: 1602–13.
   Google Scholar
• Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high and low-osmolality iodinated contrast media. Radiology 1995; 188: 171–8.
   Web of Science ®Google Scholar
• Barrett BJ, Parfrey PS, Vavasour JIM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992; 41: 1274–9.
   PubMed Web of Science ®Google Scholar
• Lautin EM, Freeman NJ, Schoenfeld AH, Bakal CW, Haramati N, Friedman AC, et al. Radiocontrast-associated renal dysfunction: incidence and risk factors. Am J Roentgenol 1991; 157: 49–58.
   PubMed Web of Science ®Google Scholar
• Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995; 47: 254–61.
   PubMed Web of Science ®Google Scholar
• Manske CL, Sprafka JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990; 89: 615–20.
   PubMed Web of Science ®Google Scholar
• McCullough PA, Wolyn R, Leslie L, Levin RN, O'Neill WW. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997; 103: 368–75.
   Google Scholar
• Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275: 1489–94.
   Google Scholar
• Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994; 331: 1416–20.
   Google Scholar
• Grynne B, Nossen JO, Bolstad B, Borch KW. Main results of the first comparative studies on Visipaque. Acta Radiol 1995; 36 (Suppl 399): 265–70.
   PubMed Web of Science ®Google Scholar
• Clauss W, Dinger J, Meissner C. Renal tolerance of iotrolan 280 - a meta-analysis of 14 double-blind studies. Eur Radiol 1995; 5: S79–84.
   Google Scholar
• Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999; 72: 701–3.
   PubMed Web of Science ®Google Scholar
• Stacul F, Cova M, Assante M, Grynne BH, Haider T. Comparison between the efficacy of dimeric and monomeric non-ionic contrast media (iodixanol vs iopromide) in urography in patients with mild to moderate renal insufficiency. Br J Radiol 1998; 71: 918–22.
   Google Scholar
• Jakobsen JA, Berg KJ, Kjwrsgaard P. Kolmannskog F, Nordal KP, Nossen JO, Rootwelt K. Angiography with nonionic x-ray contrast media in severe chronic renal failure: renal function and contrast retention. Nephron 1996; 73: 549–56.
   Google Scholar
• Deray G, Jacobs C. Radiocontrast nephrotoxicity: a review. Invest Radiol 1995; 30: 221–5.
   PubMed Web of Science ®Google Scholar
• Weinstein JM, Heyman S, Brezis M. Potential deleter-ious effect of furosemide on radiocontrast nephropathy. Nephron 1992; 62: 413–5.
   Google Scholar
• Lehnert T, Keller E, Gondolf K, Schäffner T, Pavenstädt H, Schollmeyer P. Effect of hemodialysis after contrast medium administration in patients with severe renal insufficiency. Nephrol Dial Transplant 1998; 13: 358–62.
   Google Scholar
• Waaler A, Svaland M, Fauchald P. Jakobsen Kolmannskog F, Berg KJ. Elimination of iohexol, a low osmolar nonionic contrast medium by hemodialysis in patients with chronic renal failure. Nephron 1990; 56: 81–5.
   Google Scholar
• Sterner G, Frennby B, Kurkus J, Nyman U. Does post-angiographic hemodialysis reduce the risk for contrast medium nephropathy? Scand J Urol Nephrol 2000; 34: 324–7.
   Google Scholar